|
2024 Journal Article The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysisKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Talley, Nicholas J., Koloski, Natasha, Jones, Michael P. and Holtmann, Gerald J. (2024). The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis. Neurogastroenterology and Motility, 36 (10) e14878, 1-15. doi: 10.1111/nmo.14878 |
|
2024 Conference Publication Value based assessment of same day upper and lower endoscopy for patients referred for colonoscopy with a positive immunochemical feacal occult blood testShah, Ayesha, Moy, Naomi, Whaley, Amanda, Hansen, Teressa, Virgo, Kate, Dulleck, Uwe, Koloski, Natasha, Jones, Mike and Holtmann, Gerald (2024). Value based assessment of same day upper and lower endoscopy for patients referred for colonoscopy with a positive immunochemical feacal occult blood test. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Simethicone suppresses the growth of microbes cultured from the human duodenal mucosaFairlie, Thomas, Shah, Ayesha, Lim, Yenkai, Teh, Jing-Jie, Schooth, Lauren, Morrison, Mark and Holtmann, Gerald (2024). Simethicone suppresses the growth of microbes cultured from the human duodenal mucosa. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication The duodenal mucosa-associated microbiota differs in patients based on their Rome IV classification, and has variable effects on duodenal spheroid barrier function subjectsSchooth, Lauren, Burns, Grace, Minahan, Kyra, Teh, Jing-Jie, Fairlie, Tom, Shah, Ayesha, Holtmann, Gerald and Morrison, Mark (2024). The duodenal mucosa-associated microbiota differs in patients based on their Rome IV classification, and has variable effects on duodenal spheroid barrier function subjects. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Journal Article A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interactionFairlie, Thomas, Shah, Ayesha, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna C., Mulak, Agata, Lee, Yeong Yeh, Sperber, Ami D., Koloski, Natasha, Moy, Naomi, Talley, Nicholas J., Jones, Michael P. and Holtmann, Gerald (2024). A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction. Neurogastroenterology and Motility, 36 (9) e14866, 1-13. doi: 10.1111/nmo.14866 |
|
2024 Conference Publication Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitisKhoo, Emi, Amiss, Anna, Lindsay, Niamh, Fernandes, Richard, Gilmore, Robert, Ding, John Nik, Connor, Susan J., Bryant, Robert, White, Lauren, Mohsen, Waled, Leong, Rupert, Ardalan, Zaid, Croft, Anthony, De Cruz, Peter, Lynch, Kate, An, Yoon-Kyo, Holtmann, Gerald and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication The biogeography of the mucosa-associated microbiota is associated with the presence and symptom severity of inflammatory bowel disease, proton pump inhibitor usage, and visceral sensitivitySternes, Peter, Shah, Ayesha, Pintos, Camila Ayela, Fairlie, Thomas, Koloski, Natasha, Kang, Seungha, Mcilroy, Simon, Morrison, Mark, Tyson, Gene and Holtmann, Gerald (2024). The biogeography of the mucosa-associated microbiota is associated with the presence and symptom severity of inflammatory bowel disease, proton pump inhibitor usage, and visceral sensitivity. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Conference Publication Small intestinal bacterial overgrowth as assessed by breath testing: a prospective evaluation to the gold standard aspirateShah, Ayesha, Hansen, Teressa, Fairlie, Thomas, Koloski, Natasha, Jones, Mike and Holtmann, Gerald (2024). Small intestinal bacterial overgrowth as assessed by breath testing: a prospective evaluation to the gold standard aspirate. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Journal Article Prevalence of small intestinal bacterial overgrowth in intestinal failure syndrome: A systematic review and meta‐analysisShah, Ayesha, Fairlie, Thomas, Morrison, Mark, Martin, Neal, Hammer, Karin, Hammer, Johann, Koloski, Natasha, Rezaie, Ali, Pimentel, Mark, Kashyap, Purna, Jones, Michael P. and Holtmann, Gerald (2024). Prevalence of small intestinal bacterial overgrowth in intestinal failure syndrome: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 39 (11), 1-11. doi: 10.1111/jgh.16668 |
|
2024 Journal Article An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing CholangitisShah, Ayesha, Tabibian, James, Buness, Cynthia and Holtmann, Gerald J. (2024). An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Digestive Diseases and Sciences, 69 (10), 1-6. doi: 10.1007/s10620-024-08497-4 |
|
2024 Conference Publication Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitisKhoo, Emi, Amiss, Anna, Ding, Nik S., Bryant, Robert V., Mohsen, Waled, Connor, Susan J., Leong, Rupert, Croft, Anthony, Lynch, Kate D., Sparrow, Miles, De Cruz, Peter, An, Yoon-Kyo, Holtmann, Gerald J. and Begun, Jakob (2024). Tofacitinib demonstrates preliminary efficacy in induction of remission in chronic pouchitis. Digestive Disease Week (DDW) 2024, Washington, DC, United States, 18-21 May 2024. Philadelphia, PA, United States: Elsevier. doi: 10.1016/s0016-5085(24)00988-0 |
|
2024 Conference Publication Unveiling The Gut-brain Connectivity And Links With The Immune System: Utilising Self-reported Symptoms Or The Response To A Standardised Nutrient ChallengeMoniruzzaman, Md, Shah, Ayesha, Fairlie, Thomas, Noon, Ebony, Morrison, Mark, Talley, Nicholas J., Koloski, Natasha A., Jones, Michael P. and Holtmann, Gerald J. (2024). Unveiling The Gut-brain Connectivity And Links With The Immune System: Utilising Self-reported Symptoms Or The Response To A Standardised Nutrient Challenge. Digestive Disease Week (DDW) 2024, Washington, DC United States, 18-21 May 2024. PHILADELPHIA: Elsevier. doi: 10.1016/s0016-5085(24)01585-3 |
|
2024 Conference Publication Simethicone Suppresses The Growth Of Microbes Cultured From The Human Duodenal MucosaFairlie, Thomas, Shah, Ayesha, Lim, Yenkai, Teh, Jing Jie, Schooth, Lauren F., Morrison, Mark and Holtmann, Gerald J. (2024). Simethicone Suppresses The Growth Of Microbes Cultured From The Human Duodenal Mucosa. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02466-1 |
|
2024 Conference Publication Evidence For Brain-to-gut And Gut-to-brain Pathways In General Practice Patients With Inflammatory Bowel Disease (IBD)Koloski, Natasha A., Jones, Michael P., Walker, Marjorie M., Holtmann, Gerald J. and Talley, Nicholas J. (2024). Evidence For Brain-to-gut And Gut-to-brain Pathways In General Practice Patients With Inflammatory Bowel Disease (IBD). Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)01593-2 |
|
2024 Conference Publication Evidence For Brain-to-gut Cross Talk In General Practice Patients With Gastroesophageal Reflux DiseaseKoloski, Natasha A., Jones, Michael P., Walker, Marjorie M., Holtmann, Gerald J. and Talley, Nicholas J. (2024). Evidence For Brain-to-gut Cross Talk In General Practice Patients With Gastroesophageal Reflux Disease. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)01581-6 |
|
2024 Conference Publication Oral Contraceptives, Hormonal Replacement Therapy And Risk Of Disorders Of Gut Brain Interaction (Irritable Bowel Syndrome And Functional Dyspepsia): A Primary Care Study Of Over 700,000 WomenJones, Michael P., Koloski, Natasha A., Walker, Marjorie M., Holtmann, Gerald J., Shah, Ayesha, Eslick, Guy D. and Talley, Nicholas J. (2024). Oral Contraceptives, Hormonal Replacement Therapy And Risk Of Disorders Of Gut Brain Interaction (Irritable Bowel Syndrome And Functional Dyspepsia): A Primary Care Study Of Over 700,000 Women. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02652-0 |
|
2024 Conference Publication Impact Of Economic And Psychosocial Factors On Symptom Severity In Patients With Disorders Of Gut-brain Interaction During The COVID-19 Pandemic: A Systematic Review And Meta-analysisKulin, Dmitrii, Shah, Ayesha, Fairlie, Thomas, Wong, Reuben K., Fang, Xiucai, Ghoshal, Uday C., Kashyap, Purna, Mulak, Agata, Lee, Yeong Yeh and Holtmann, Gerald J. (2024). Impact Of Economic And Psychosocial Factors On Symptom Severity In Patients With Disorders Of Gut-brain Interaction During The COVID-19 Pandemic: A Systematic Review And Meta-analysis. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)03354-7 |
|
2024 Journal Article Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?Shah, Ayesha and Holtmann, Gerald (2024). Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?. Alimentary Pharmacology and Therapeutics, 59 (10), 1290-1291. doi: 10.1111/apt.17990 |
|
2024 Conference Publication Small Intestinal Bacterial Overgrowth As Assessed By Breath Testing: A Prospective Evaluation To The Gold Standard AspirateHansen, Teressa J., Shah, Ayesha, Fairlie, Thomas, Koloski, Natasha A., Jones, Michael P. and Holtmann, Gerald J. (2024). Small Intestinal Bacterial Overgrowth As Assessed By Breath Testing: A Prospective Evaluation To The Gold Standard Aspirate. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)00876-x |
|
2024 Conference Publication Small Intestinal Bacterial Overgrowth In Intestinal Failure: A Systematic Review And Meta-analysisFairlie, Thomas, Shah, Ayesha, Martin, Neal, Jones, Michael P., Koloski, Natasha A., Morrison, Mark and Holtmann, Gerald J. (2024). Small Intestinal Bacterial Overgrowth In Intestinal Failure: A Systematic Review And Meta-analysis. Digestive Disease Week (DDW) 2024, Chicago, IL United States, 18-21 May 2024. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(24)02701-x |
